The Spectrum of Venetoclax-Based Treatments in Acute Myeloid Leukemia.

Cancers (Basel) · 2026 · PMC13114347 · PMID 42073528

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients with mutations in signaling pathway genes ( FLT3 , NRAS , KRAS , NF1 , PTPN11 , JAK / STAT , KIT , CSF3R ) showed a trend to shorter survival, particularly evident for those with RAS/RTK pathway signaling [ 155 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.